TB-500

TB or Wolverine

Recovery & Performance

CAS

77591-33-4

Molecular Weight

796

Da

Animal Only

A synthetic peptide derived from Thymosin Beta-4, a protein naturally present in human cells. Studied in animal models for muscle and tendon repair, wound healing, and cardiac tissue recovery. Widely used alongside BPC-157 as a recovery stack in the biohacking community. No human clinical trials completed to date. Note: often confused with TB-500 Fragment — CAS 77591-33-4 confirms full Thymosin Beta-4.

Injectable

Intranasal Suitable

Uncertain

Research Compound

Research Quality Score
7 dimensions · 100 points total · Methodology by PeptideClear
41/100
Limited Evidence
Study Design
5/25
Sample Size
4/20
Replication
10/20
Journal Impact Factor
10/15
Funding Independence
7/10
Population Diversity
0/5
Researcher h-Index
5/5
Dimension Breakdown
Study DesignQuality of research methodology — RCT, observational, animal, or in vitro
5/ 25
Sample SizeNumber of participants across studies supporting this compound
4/ 20
ReplicationIndependent reproduction of findings by separate research groups
10/ 20
Journal Impact FactorPrestige of journals where primary studies were published
10/ 15
Funding IndependenceDegree to which research was funded independently of industry
7/ 10
Population DiversityDiversity of study participants across age, sex, and ethnicity
0/ 5
Researcher h-IndexCitation credibility of the primary research team
5/ 5
⚠️

Animal evidence note: Score reflects current human evidence. Animal evidence may be stronger than the total score indicates — this compound has not yet been studied in human trials.

Scored by PeptideClear editorial team · Based on publicly available literature
StrongModerateLimitedWeak

Community Signal

Community signal is substantial and skews positive for injury recovery applications, though not as dramatically as BPC-157. Tendon and ligament injury reports are the dominant use case discussed, users frequently stack TB-500 with BPC-157 for what they call synergistic healing effects. Systemic vs localized injection debate is active, with many users preferring systemic administration based on TB-500's mechanism. Hair growth as a side effect is reported frequently enough to have its own community discussion thread on r/tressless and r/Peptides. Side effect reports are notably rare. The animal-only evidence base generates the same tension as BPC-157, a large anecdotal positive signal against thin formal research.

We break down one compound like this every week

The Honest Dose — free, no sponsorships, no agenda. Just the evidence.

Subscribe free →

What It Is

TB-500 is a synthetic peptide derived from Thymosin Beta-4, a naturally occurring protein found in virtually all human and animal cells. It is one of the most abundant proteins in the body and plays a central role in cell building and repair. TB-500 specifically replicates the active region of Thymosin Beta-4 responsible for most of its regenerative properties.

Mechanism of Action

TB-500 works primarily by up-regulating actin, a protein essential for cell structure, movement, and division. By promoting actin polymerization it accelerates cell migration to injury sites, stimulates new blood vessel formation, and reduces inflammation. It also modulates stem cell differentiation, which may contribute to its reported tissue repair properties across muscle, tendon, ligament, skin, and cardiac tissue.

Use Cases

In animal research TB-500 has been studied for muscle injury recovery, tendon and ligament repair, cardiac tissue healing following heart attack, wound healing, and hair regrowth. It is widely used alongside BPC-157 in the biohacking and athletic performance community as a recovery stack. Some limited human data exists from Thymosin Beta-4 clinical trials, though TB-500 itself has not been studied in human trials.

Known Risks

Human safety data is limited. Considerations include: no established safe human dosing range, unknown long-term effects, theoretical concern around cancer cell migration given its role in promoting cell movement, potential interaction with anticoagulants due to effects on platelet aggregation. Not recommended during pregnancy. As with BPC-157, individuals with a history of cancer should exercise significant caution given the peptide's pro-angiogenic and cell-migration-promoting properties.

Available Forms

Injectable (subcutaneous or intramuscular). No established oral form — TB-500 is a larger peptide and is generally considered to have poor oral bioavailability. Typically sold as a lyophilized powder requiring reconstitution with bacteriostatic water before injection.

Regulatory Status

TB-500 is not FDA approved for human use. Sold as a research compound labeled "not for human consumption." Not currently on any FDA compounding list. Legal to purchase and possess but not to administer as a drug without a prescription.

Sources

https://pubmed.ncbi.nlm.nih.gov/16099219/

https://pubmed.ncbi.nlm.nih.gov/15565145/

https://pubmed.ncbi.nlm.nih.gov/20536453/

Similar Compounds

BPC-157, Ipamorelin, GHK-Cu

Enjoyed this profile? Get one compound broken down in depth every week in The Honest Dose.

Join The Honest Dose →

Last Reviewed